ID   AZOR2_PSEAE             Reviewed;         202 AA.
AC   Q9I2E2;
DT   26-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-FEB-2021, entry version 101.
DE   RecName: Full=FMN-dependent NADH:quinone oxidoreductase 2 {ECO:0000255|HAMAP-Rule:MF_01216};
DE            EC=1.6.5.- {ECO:0000255|HAMAP-Rule:MF_01216, ECO:0000269|PubMed:24915188};
DE   AltName: Full=Azo-dye reductase 2 {ECO:0000255|HAMAP-Rule:MF_01216};
DE   AltName: Full=FMN-dependent NADH-azo compound oxidoreductase 2 {ECO:0000255|HAMAP-Rule:MF_01216};
DE   AltName: Full=FMN-dependent NADH-azoreductase 2 {ECO:0000255|HAMAP-Rule:MF_01216};
DE            EC=1.7.1.17 {ECO:0000255|HAMAP-Rule:MF_01216, ECO:0000269|PubMed:20417637};
GN   Name=azoR2 {ECO:0000255|HAMAP-Rule:MF_01216, ECO:0000303|PubMed:20417637};
GN   OrderedLocusNames=PA1962;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=20417637; DOI=10.1016/j.jmb.2010.04.023;
RA   Ryan A., Laurieri N., Westwood I., Wang C.J., Lowe E., Sim E.;
RT   "A novel mechanism for azoreduction.";
RL   J. Mol. Biol. 400:24-37(2010).
RN   [3]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=24915188; DOI=10.1371/journal.pone.0098551;
RA   Ryan A., Kaplan E., Nebel J.C., Polycarpou E., Crescente V., Lowe E.,
RA   Preston G.M., Sim E.;
RT   "Identification of NAD(P)H quinone oxidoreductase activity in azoreductases
RT   from P. aeruginosa: azoreductases and NAD(P)H quinone oxidoreductases
RT   belong to the same FMN-dependent superfamily of enzymes.";
RL   PLoS ONE 9:e98551-e98551(2014).
CC   -!- FUNCTION: Quinone reductase that provides resistance to thiol-specific
CC       stress caused by electrophilic quinones (PubMed:24915188). Reduces both
CC       benzoquinones and naphthoquinones efficiently (PubMed:24915188).
CC       {ECO:0000269|PubMed:24915188}.
CC   -!- FUNCTION: Also exhibits azoreductase activity. Catalyzes the reductive
CC       cleavage of the azo bond in aromatic azo compounds to the corresponding
CC       amines (PubMed:20417637). Preferred substrates are the large bis-azo
CC       dye Ponceau BS, amaranth and tropaeolin O (PubMed:20417637).
CC       {ECO:0000269|PubMed:20417637}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 a quinone + H(+) + NADH = 2 a 1,4-benzosemiquinone + NAD(+);
CC         Xref=Rhea:RHEA:65952, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:132124, ChEBI:CHEBI:134225;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01216,
CC         ECO:0000269|PubMed:24915188};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65953;
CC         Evidence={ECO:0000269|PubMed:24915188};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=anthranilate + N,N-dimethyl-1,4-phenylenediamine + 2 NAD(+) =
CC         2-(4-dimethylaminophenyl)diazenylbenzoate + 2 H(+) + 2 NADH;
CC         Xref=Rhea:RHEA:55872, ChEBI:CHEBI:15378, ChEBI:CHEBI:15783,
CC         ChEBI:CHEBI:16567, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:71579; EC=1.7.1.17; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_01216, ECO:0000269|PubMed:20417637};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:55874;
CC         Evidence={ECO:0000269|PubMed:20417637};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01216};
CC       Note=Binds 1 FMN per subunit. {ECO:0000255|HAMAP-Rule:MF_01216};
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_01216}.
CC   -!- MISCELLANEOUS: Rate of quinone reduction is higher than reduction of
CC       azo substrates, suggesting the enzyme is better suited for carrying out
CC       quinone rather than azo reduction. {ECO:0000269|PubMed:24915188}.
CC   -!- SIMILARITY: Belongs to the azoreductase type 1 family.
CC       {ECO:0000255|HAMAP-Rule:MF_01216}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG05350.1; -; Genomic_DNA.
DR   PIR; A83402; A83402.
DR   RefSeq; NP_250652.1; NC_002516.2.
DR   RefSeq; WP_003113473.1; NZ_QZGE01000030.1.
DR   SMR; Q9I2E2; -.
DR   PaxDb; Q9I2E2; -.
DR   EnsemblBacteria; AAG05350; AAG05350; PA1962.
DR   GeneID; 877936; -.
DR   KEGG; pae:PA1962; -.
DR   PATRIC; fig|208964.12.peg.2045; -.
DR   PseudoCAP; PA1962; -.
DR   HOGENOM; CLU_088964_0_0_6; -.
DR   InParanoid; Q9I2E2; -.
DR   OMA; REGWDHS; -.
DR   PhylomeDB; Q9I2E2; -.
DR   BioCyc; PAER208964:G1FZ6-2000-MONOMER; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0009055; F:electron transfer activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0010181; F:FMN binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0016652; F:oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor; IEA:UniProtKB-UniRule.
DR   GO; GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:PseudoCAP.
DR   GO; GO:0016661; F:oxidoreductase activity, acting on other nitrogenous compounds as donors; IEA:InterPro.
DR   Gene3D; 3.40.50.360; -; 1.
DR   HAMAP; MF_01216; Azoreductase_type1; 1.
DR   InterPro; IPR003680; Flavodoxin_fold.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR023048; NADH-azoreductase_FMN-depdnt.
DR   Pfam; PF02525; Flavodoxin_2; 1.
DR   SUPFAM; SSF52218; SSF52218; 1.
PE   1: Evidence at protein level;
KW   Flavoprotein; FMN; NAD; Oxidoreductase; Reference proteome.
FT   CHAIN           1..202
FT                   /note="FMN-dependent NADH:quinone oxidoreductase 2"
FT                   /id="PRO_0000166348"
FT   NP_BIND         15..17
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01216"
FT   NP_BIND         95..98
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01216"
FT   NP_BIND         139..142
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01216"
FT   BINDING         9
FT                   /note="FMN"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01216"
SQ   SEQUENCE   202 AA;  21290 MW;  B6F21D0AEDCD4705 CRC64;
     MKLLHIDSSI LGDASASRQL SAELVQAWRQ NEDGLDVTYR DLAADAVAHF SALTLAAGST
     PAELRDAALK HEVAVGEEVL EEFLAADVVV IGAPMYNFTI SSQLKAWIDR IAVAGKTFRY
     TENGPVGLAG DKKVVIVSTA GGVHAGQPTG AAHEGYLRTV LGFFGITDIE VVRAEGLAYG
     EEPRTQAIAA ARRQIAGQFA AA
//
